• Alpha Fetoprotein Antigen (AFP), highly purified, from human hepatocarcinoma cell line |
• Alpha Fetoprotein (AFP) monoclonal antibody, highly purified, from mouse ascites |
• Breast Tumor Antigen (Ca15-3), highly purified, from human fluids |
• Breast Tumor Antigen (Ca15-3), highly purified, from human ductal breast adenocarcinoma cell line |
• Breast Tumor Antigen (Ca15-3), highly purified, from human pleural/ascites fluid |
• Breast tumor cell line pellet from human cell line |
• Breast tumor cell line pellet (RNA preserved), from human cell line |
• MUC-1 (Breast Tumor) Antigen, monoclonal antibody, highly purified, from mouse ascites |
• MUC-1 (Breast Tumor) Antigen Monoclonal Antibody, highly purified, cell culture supernatant |
• Carcinoembryonic Antigen (CEA), highly purified, from human pleural/ascites fluid |
• Carcinoembryonic Antigen (CEA), highly purified, from human human colon adenocarcinoma cell line |
• Carcinoembryonic Antigen (CEA) monoclonal antibody, highly purified, cell culture supernatant |
• CEA (carcinoembryonic antigen) antiserum from goat |
• Cytokeratin-19 Antigen (Cyfra-21-1), highly purified, from human adenocarcinoma cell line |
• Ferritin Antigen, highly purified, from human liver |
• Gastrointestinal Tumor Antigen (CA19-9), highly purified, cell culture concentrate, from human colon adenocarcinoma cell line |
• Gastrointestinal Tumor Antigen (CA19-9), highly purified, cell culture concentrate, from human pleural/ascites fluid |
• Gastrointestinal Tumor Marker CA 19-9, monoclonal antibody, highly purified, from mouse ascites fluid |
• Gastrointestinal Tumor Antigen (CA242), highly purified, from human colon adenocarcinoma cell line |
• Gastrointestinal Tumor Antigen (CA50), highly purified, from human colon adenocarcinoma |
• Ovarian Tumor Antigen (Ca125), highly purified, from human pleural/ascites fluid |
• Ovarian Tumor Antigen (Ca125), highly purified, from human ovarian adenocarcinoma cell line |
• Anti-ovarian tumor antigen Ca125, monoclonal antibody, highly purified, from mouse ascites |
• Prostate Specific Antigen (PSA), highly purified, from human seminal plasma |
• TAG72-4 Antigen (Ca72-4), highly purified, from human pleural/ascites fluid |
• TAG72-4 Antigen (Ca72-4), highly purified, from human colon adenocarcinoma fluid |
• Tumor Marker High Control |
• Tumor Marker Low Control |
• C-Reactive Protein (CRP) Antigen, highly purified, from human pleural and ascites fluid |
• C-Reactive Protein (CRP) control, from human fluids and human serum |
• CRP deficient serum control, from CRP depleted human serum |
• Serum Amyloid A (SAA), positive human plasma |
• AFP (alpha fetoprotein) control |
• HCG (human chorionic gonadotropin) control |
• Estriol control |
• Ferritin control |
• Anti-Streptolysin (ASO) control |
• Perfusion bioreactor services, in vitro cell culture production |
• Cell line preparation |
• Subcloning services |
• Hybridoma services |
• Immunization services |
• Breast Cancer Antigen (CA 15-3) from human fluids |
• Ovarian Cancer Antigen (CA 125) from human fluids |
• Gastrointestinal Cancer Antigen (CA 19-9) |
• Gastric Cancer Antigen (CA 72-4) from human fluids |
• Carcinoembryonic Antigen (CEA) from human meconium |
• Alpha Feto Protein (AFP) from human cord blood |
• Hepatitis Surface Antigen (HBsAg-ay) from human blood |
• Hepatitis Surface Antigen (HBsAg-ad) from human blood |
• C Reactive Protein (CRP) from human ascites fluid |
• Myeloperoxidase (MPO) |
• Alpha 1 Microglobulin (A1M) from human urine |
• Beta 2 Microglobulin (B2M) from human urine |
• Cystatin C (Cys-C) from human urine |
• Prostate Specific Antigen (PSA) |
• PSA-ACT (alpha 1-antichymotrypsin - prostate specific antigen) complex from human seminal plasma (PSA) and from human blood plasma (ACT) |
• Development of customized monoclonal antibodies |
• Development of customized polyclonal antibodies |
• Development of protein purification protocols |
